Powered by LumidaWealth.com
Lumida News
  • Home
  • EarningsNEW
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us
No Result
View All Result
Lumida News
  • Home
  • EarningsNEW
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us
No Result
View All Result
Lumida News
No Result
View All Result
  • Lumida Wealth
  • Lumida Ledger
  • LUMIDA ETF
  • About Us
Home Themes AI

Microsoft Tries to Catch Up in AI With Healthcare Push, Harvard Deal

by Team Lumida
October 9, 2025
in AI
Reading Time: 3 mins read
A A
0
Microsoft’s AI Ambitions: A Costly Path Forward

FILE PHOTO: A Microsoft logo is seen in Los Angeles, California, U.S. June 14, 2016. REUTERS/Lucy Nicholson

Share on TelegramShare on TwitterShare on FacebookShare on LinkedinShare on Whatsapp

Key Takeaways

Powered by lumidawealth.com

  • Microsoft is developing its own AI chatbot capabilities to reduce reliance on OpenAI and establish its Copilot assistant as a consumer brand, focusing initially on healthcare.
  • A major update to Copilot, expected soon, will integrate licensed content from Harvard Medical School’s Harvard Health Publishing to provide credible, tailored healthcare information.
  • Microsoft aims for Copilot to offer medical advice closer to what users might receive from healthcare professionals, addressing concerns about chatbot accuracy in medical contexts.
  • The company is also developing tools to help users find healthcare providers based on needs and insurance coverage.
  • Microsoft AI chief Mustafa Suleyman has prioritized healthcare, expanding internal AI teams and developing AI tools that outperform doctors in disease diagnosis at lower costs.
  • Despite extending its partnership with OpenAI, Microsoft is investing heavily in building its own AI models and infrastructure to eventually replace some OpenAI workloads.

What happened?

Microsoft is accelerating efforts to build proprietary AI chatbot technology, with healthcare as a strategic focus area. The upcoming Copilot update will leverage Harvard’s trusted medical content to improve reliability and user trust. This move reflects Microsoft’s ambition to compete more independently in the AI space while maintaining a partnership with OpenAI.

Why it matters

Healthcare is a high-value, sensitive sector where accurate AI assistance can have significant impact, making it a key battleground for AI providers. Microsoft’s push into healthcare AI could differentiate its Copilot offering and expand its consumer and enterprise AI footprint. For investors, Microsoft’s AI strategy signals a long-term commitment to innovation and competition in a rapidly evolving market.

What’s next?

Monitor the rollout and user reception of the updated Copilot healthcare features. Watch Microsoft’s progress in developing homegrown AI models and reducing dependence on OpenAI. Track competitive moves by other AI players in healthcare and enterprise sectors. Investor focus should include Microsoft’s AI revenue growth, partnerships, and technological advancements.

Source
Previous Post

China Imposes New Controls Over Rare-Earth Exports

Next Post

Trump Calls for Jailing of Chicago Mayor and Illinois Governor

Recommended For You

The Best Argument Against an AI Bubble Is That Capital Is Being Rationed, and This Week Proved It

by Team Lumida
7 hours ago
The Best Argument Against an AI Bubble Is That Capital Is Being Rationed, and This Week Proved It

Chiavarone says bubble worriers are several years early. His weakest claim is that debt plays a limited role.

Read more

Oracle Invoked Force Majeure Against Its Own Developer, and Blue Owl Is Raising $6 Billion Against the Same Model

by Team Lumida
1 day ago
Crude Jumps 5.2% on Houthi Attacks and Gulf Shut-Ins as Stocks Retreat From Records

Activists found the attack surface is water and air permits, which community payments do not address.

Read more

The DeepSeek Ban Covers Any Product Built on Its Models, Which Is the Problem With Banning Open Weights

by Team Lumida
1 day ago
The DeepSeek Ban Covers Any Product Built on Its Models, Which Is the Problem With Banning Open Weights

Issued July 24, made public Monday. The 60-day window to request exceptions closed before anyone knew.

Read more

Some AI Companies Are Funding Candidates Who Want Strong Federal Regulation, Which Is Not the Contradiction It Appears

by Team Lumida
5 days ago
Some AI Companies Are Funding Candidates Who Want Strong Federal Regulation, Which Is Not the Contradiction It Appears

Federal rules that preempt local ones would help companies facing municipal moratoria. Light-touch advocates want no constraint at all.

Read more

ByteDance Is Buying Custom Chips From Taiwan Because It Cannot Buy Nvidia’s, Which US Rules Permit

by Team Lumida
6 days ago
ByteDance Is Buying Custom Chips From Taiwan Because It Cannot Buy Nvidia’s, Which US Rules Permit

It is weighing capital spending of up to $70 billion this year, more than TSMC's record $64 billion.

Read more

A Data Center Developer Is Paying Kansas Households $1,000 a Year for a Decade, Which Is About $83 a Month

by Team Lumida
1 week ago
A Data Center Developer Is Paying Kansas Households $1,000 a Year for a Decade, Which Is About $83 a Month

The project covers 1,400 acres and will support 250 permanent jobs. Community payments are becoming a standard development cost.

Read more

ASML Raises 2026 Guidance to €44-45bn; Cannot Fully Meet 2027-2028 Demand; Multi-Year Forward Orders Extend to 2029-2030, Validating Sustained AI Capex Cycle

by Team Lumida
1 week ago
ASML Raises 2026 Guidance to €44-45bn; Cannot Fully Meet 2027-2028 Demand; Multi-Year Forward Orders Extend to 2029-2030, Validating Sustained AI Capex Cycle

ASML Q3: €11.66bn revenue; raised 2026 to €44-45bn. Cannot meet 2027-2028 demand with current plans; investigating >30% capacity increase. CEO Fouquet: 'customers asking daily for more tools.' Customers...

Read more

Nvidia Adds $2 Billion to Europe While Funding a Startup Whose Own Valuation Fell 38%

by Team Lumida
1 week ago
Nvidia Adds $2 Billion to Europe While Funding a Startup Whose Own Valuation Fell 38%

Huang and Alibaba's chairman are now giving Europe identical advice on open models. Both sell into the answer.

Read more

SpaceX Agrees to NYC Council AI Safety Testimony After Subpoena Threat; Musk-Backed Grok Testifies Friday as Deepfake Porn Lawsuits Mount and Federal Agencies Question Pentagon Usage

by Team Lumida
1 week ago
SpaceX Agrees to NYC Council AI Safety Testimony After Subpoena Threat; Musk-Backed Grok Testifies Friday as Deepfake Porn Lawsuits Mount and Federal Agencies Question Pentagon Usage

SpaceX testifying Fri (Oct 18) 10 AM to NYC Council tech committee. Originally subpoenaed Sept 28 for Oct 5 hearing; skipped. Anthropic, OpenAI, Google, Meta testified Oct 5....

Read more

Meta’s Muse Wonder Reaches AI Frontier, Zuckerberg Commits to Further Vast Spending; Stock Up 10% Since Muse Launch Despite Amazon Throttling Agents and Privacy Concerns

by Team Lumida
1 week ago
Meta’s Muse Wonder Reaches AI Frontier, Zuckerberg Commits to Further Vast Spending; Stock Up 10% Since Muse Launch Despite Amazon Throttling Agents and Privacy Concerns

Meta released Muse Wonder; Zuckerberg: at AI 'frontier.' Outperforms Claude Opus 5.5, GPT-6 Astra on benchmarks. Muse app most-downloaded US both platforms. Stock +10% since Sept. $1.8T company....

Read more
Next Post
Trump Tariffs Leave Key Questions on China Supply Chain Rules Unanswered

Trump Calls for Jailing of Chicago Mayor and Illinois Governor

woman in white dress shirt and black pants standing near brown wooden shelf

Trump Excludes Generics From Big Pharma Tariff Plan

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Related News

A Verizon Bond Issued in May Hit Its Widest Ever Spread After SpaceX Said It Will Become a Major Mobile Carrier

A Verizon Bond Issued in May Hit Its Widest Ever Spread After SpaceX Said It Will Become a Major Mobile Carrier

October 9, 2026
a sandy desert with a tall tower

US Sends USS Gerald R. Ford to Middle East as Iran Tensions Rise and Military Options Expand

February 13, 2026
Why Alibaba’s $2.8 Billion AI Investment Could Shake Up the Market

Alibaba and E-mart Forge $4B E-commerce Alliance in South Korea

December 26, 2024

Subscribe to Lumida Ledger

Browse by Category

  • Lifestyle
    • Family Office
    • Health and Longevity
    • Legacy
    • Next Gen Wealth
    • Trust, Tax, and Estate
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Latest
    • Macro
    • Markets
    • Real Estate
  • Opinions
    • Investing Philosophy
    • Op-Ed
  • Research
    • Trackers
  • Themes
    • Aging & Longevity
    • AI
    • Biotech
    • CRE
    • Cybersecurity
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
    • Software
Facebook Twitter Instagram Youtube TikTok LinkedIn
Lumida News

Premium insights to help you invest beyond the ordinary. Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser

CATEGORIES

  • Aging & Longevity
  • AI
  • Alt Assets
  • Biotech
  • CRE
  • Crypto
  • Cybersecurity
  • Digital Assets
  • Equities
  • Family Office
  • Health and Longevity
  • Investing Philosophy
  • Latest
  • Legacy
  • Legacy Brands
  • Lifestyle
  • Macro
  • Markets
  • News
  • Next Gen Wealth
  • Nuclear Renaissance
  • Op-Ed
  • Private Credit
  • Real Estate
  • Software
  • Themes
  • Trackers
  • Trust, Tax, and Estate

BROWSE BY TAG

AI AI chips Amazon Apple Artificial Intelligence Banking Bank of America Bitcoin China Commercial Real Estate CPI Crypto Donald Trump EARNINGS ELON MUSK Ethereum Federal Reserve financial services generative AI Goldman Sachs Google India Inflation Interest Rates Investment Strategy Japan Jerome Powell JPMorgan Markets Meta Microsoft Nasdaq Novo Nordisk Nuclear Energy Nvidia oil OpenAI private equity S&P 500 SEC stock market Tech Stocks tesla Trump Whale Watch

© 2025 Lumida Wealth Management LLC is an SEC registered investment adviser. Privacy Policy. Cookies Policy.
Disclaimer Important Information This site is for informational purposes only. Information presented on this site does not constitute as investment advice.

Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser. SEC registration does not constitute an endorsement of the firm by the Commission nor does it indicate that the adviser has attained a particular level of skill or ability.

Lumida's website (referred to herein as the "Website") is limited to the dissemination of general information pertaining to its advisory services, together with access to additional investment-related information, publications, and links. Accordingly, the publication of the Website on the Internet should not be construed by any client and/or prospective client Lumida’s solicitation to effect, or attempt to effect transactions in securities, or the rendering of personalized investment advice for compensation, over the Internet.

Any subsequent, direct communication by Lumida with a prospective client will be conducted by a representative that is either registered or qualifies for an exemption or exclusion from registration in the state where the prospective client resides.

‍Lead Capture Forms: By submitting your contact information in the forms on this site, you are not obligated to invest in Lumida's product or services.
‍Address: Lumida Wealth Management, 25 W 39th Street Suite 700, New York, NY 10018

No Result
View All Result
  • Home
  • Earnings
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us

© 2025 Lumida Wealth Management LLC is an SEC registered investment adviser. Privacy Policy. Cookies Policy.
Disclaimer Important Information This site is for informational purposes only. Information presented on this site does not constitute as investment advice.

Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser. SEC registration does not constitute an endorsement of the firm by the Commission nor does it indicate that the adviser has attained a particular level of skill or ability.

Lumida's website (referred to herein as the "Website") is limited to the dissemination of general information pertaining to its advisory services, together with access to additional investment-related information, publications, and links. Accordingly, the publication of the Website on the Internet should not be construed by any client and/or prospective client Lumida’s solicitation to effect, or attempt to effect transactions in securities, or the rendering of personalized investment advice for compensation, over the Internet.

Any subsequent, direct communication by Lumida with a prospective client will be conducted by a representative that is either registered or qualifies for an exemption or exclusion from registration in the state where the prospective client resides.

‍Lead Capture Forms: By submitting your contact information in the forms on this site, you are not obligated to invest in Lumida's product or services.
‍Address: Lumida Wealth Management, 25 W 39th Street Suite 700, New York, NY 10018